TRVI
Trevi Therapeutics Inc
14.40$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3,613.1% | – | – | – | -6,541.1% | – | – | – | – | – | – | – | |
| – | 19.9% | – | – | – | 26.0% | – | – | – | – | – | – | – | |
| – | 303.4% | – | – | – | 628.1% | – | – | – | – | – | – | – | |
| – | 418.2% | – | – | – | 691.1% | – | – | – | – | – | – | – | |
| – | 12.5% | – | – | – | 4.8% | – | – | – | – | – | – | – | |
| – | 7,298.3% | – | – | – | -16,350.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -21.2% | – | – | – | – | – | – | – | |
| – | -30.7% | – | – | – | 35,251.4% | – | – | – | – | – | – | – | |
| – | 3,654.5% | – | – | – | 12,359.6% | – | – | – | – | – | – | – | |
| – | -3,625.6% | – | – | – | -6,545.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.